HKSE - Delayed Quote HKD

Transcenta Holding Limited (6628.HK)

Compare
0.610 0.000 (0.00%)
At close: 3:59:31 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
53,849.000
53,849.000
101,892.000
50,242.000
80,980.000
Cost of Revenue
39,451.000
39,451.000
82,003.000
40,874.000
62,778.000
Gross Profit
14,398.000
14,398.000
19,889.000
9,368.000
18,202.000
Operating Expense
478,308.000
478,308.000
441,547.000
513,215.000
357,750.000
Operating Income
-463,910.000
-463,910.000
-421,658.000
-503,847.000
-339,548.000
Net Non Operating Interest Income Expense
-459.000
-459.000
6,356.000
-7,378.000
-10,207.000
Pretax Income
-462,820.000
-462,820.000
-406,991.000
-1,715,648.000
-323,010.000
Tax Provision
-250.000
-250.000
-246.000
-105.000
-110.000
Net Income Common Stockholders
-462,570.000
-462,570.000
-406,745.000
-1,715,543.000
-316,626.000
Diluted NI Available to Com Stockholders
-462,570.000
-462,570.000
-406,745.000
-1,715,543.000
-316,626.000
Basic EPS
-1.14
--
-0.94
-9.34
-0.71
Diluted EPS
-1.14
--
-0.94
-9.34
-0.71
Basic Average Shares
407,032.399
--
432,827.091
183,599.740
445,331.917
Diluted Average Shares
407,032.399
--
432,827.091
183,599.740
445,331.917
Total Expenses
517,759.000
517,759.000
523,550.000
554,089.000
420,528.000
Net Income from Continuing & Discontinued Operation
-462,570.000
-462,570.000
-406,745.000
-1,715,543.000
-316,626.000
Normalized Income
-461,105.791
-461,105.791
-406,700.027
-1,740,679.462
-316,617.003
Interest Income
15,558.000
15,558.000
23,992.000
7,789.000
5,863.000
Interest Expense
16,017.000
16,017.000
17,636.000
15,167.000
16,070.000
Net Interest Income
-459.000
-459.000
6,356.000
-7,378.000
-10,207.000
EBIT
-446,803.000
-446,803.000
-389,355.000
-1,700,481.000
-306,940.000
EBITDA
-393,012.000
-393,012.000
-334,088.000
-1,648,000.000
-264,812.000
Reconciled Cost of Revenue
39,451.000
39,451.000
82,003.000
40,874.000
62,778.000
Reconciled Depreciation
53,791.000
53,791.000
55,267.000
52,481.000
42,128.000
Net Income from Continuing Operation Net Minority Interest
-462,570.000
-462,570.000
-406,745.000
-1,715,543.000
-316,626.000
Total Unusual Items Excluding Goodwill
-1,465.000
-1,465.000
-45.000
25,138.000
-9.000
Total Unusual Items
-1,465.000
-1,465.000
-45.000
25,138.000
-9.000
Normalized EBITDA
-391,547.000
-391,547.000
-334,043.000
-1,673,138.000
-264,803.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
-0.791
-0.791
-0.027
1.538
-0.003
12/31/2020 - 9/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0ITA.BE Satellos Bioscience Inc
0.6700
+4.69%
 
3681.HK SinoMab BioScience Limited
1.050
-5.41%
 
1228.HK CANBRIDGE-B
0.152
-1.94%
 
6978.HK Immunotech Biopharm Ltd
2.550
-7.27%
 
1167.HK JACOBIO-B
1.310
-5.07%
 
1541.HK IMMUNEONCO-B
6.140
+1.99%
 
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
 
2105.HK Laekna, Inc.
10.840
-8.75%
 
1521.HK FRONTAGE
1.560
+3.31%
 
1530.HK 3SBIO
6.030
-1.95%